glp 1 adoption GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Appetite Remains High. But

Precision Peptide Genetic Testing: Personalizing Your GLP-1 Therapy PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on after your first month of treatment, which analyzes 14 metabolic pathways and 150+ genetic insights specific to how your body responds to semaglutide and other peptide therapies

A 2025 Cochrane review of 18 studies confirmed that semaglutide (Wegovy/Ozempic) results in approximately 10.7% greater weight loss compared to placebo, with high-certainty evidence [6]

Targeting Dementia and Metabolic Disease With Cannabis and Cannabidiol Both cognitive neurodegenerative disorders, such as AD, and metabolic disease that includes DM are chronic progressive disorders that call for innovative therapies to address the intimate link between these disease entities

The impact of obesity on IBD has been examined and summarized in a recent review Trusted Source PubMed Central Go to source

The staff/team at TRTMD are absolutely amazing in these knowledge, care and support